Insights into the Activity, Differential Expression, Mutual Regulation, and Functions of Matrix Metalloproteinases and A Disintegrin and Metalloproteinases in Hypertension and Cardiac Disease
Authors:
- Ana-Maria BosoneaABAna-Maria Bosonea
- Xiang WangXWXiang Wang
- Carlos Fernandez-PatronCFCarlos Fernandez-Patron
- 17 November 2012
- journal article
- review article
- Published by S. Karger AG in Journal of Vascular Research
- Vol. 50 (1) , 52-68
Abstract
Hypertensive cardiac disease is a major cause of death worldwide. Causative factors of hypertension include environmental stressors, genetic predisposition, and common morbidities of lipid metabolism such as obesity and diabetes. These factors pathologically elevate the systemic production of vasoconstrictive G-protein-coupled receptor agonists. Pathological concentrations of these agonists upregulate the gene expression and proteolytic activity of matrix metalloproteinases (MMPs) and A disintegrin and metalloproteinases (ADAMs). Among the metalloproteinases that act in concert with other mediators to elevate the systemic blood pressure and to modulate the development of cardiovascular hypertrophy and fibrosis processes are MMP-2, MMP-7, ADAM-12, and ADAM-17. This review offers insights into the activity, differential expression, mutual regulation, and functions of these metalloproteinases. We further review evidence linking them to transcription factors, carrier proteins, and receptors for lipids. The emerging links between metalloproteinases and lipids are intriguing and suggest new therapeutic targets in hypertensive cardiac disease.Keywords
This publication has 190 references indexed in Scilit:
- An Emerging Role of Degrading Proteinases in Hypertension and the Metabolic Syndrome: Autodigestion and Receptor CleavageCurrent Hypertension Reports, 2011
- Inhibition of matrix metalloproteinase‐2 improves endothelial function and prevents hypertension in insulin‐resistant ratsBritish Journal of Pharmacology, 2011
- Cell cholesterol modulates metalloproteinase‐dependent shedding of low‐density lipoprotein receptor‐related protein‐1 (LRP‐1) and clearance functionThe FASEB Journal, 2011
- Matrix metalloproteinases and small artery remodelingDrug Discovery Today: Disease Models, 2011
- Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesisBiochemical and Biophysical Research Communications, 2009
- Oleic acid content is responsible for the reduction in blood pressure induced by olive oilProceedings of the National Academy of Sciences, 2008
- Urokinase directly activates matrix metalloproteinases-9: A potential role in glioblastoma invasionBiochemical and Biophysical Research Communications, 2008
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseBiochemical Pharmacology, 2008
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006